bt474 cell lines Search Results


93
CLS Cell Lines Service GmbH bt474 cells
MTT-assay. ( A ) MTT-assay T-47D cells, ( B ) MTT-assay <t>BT474</t> cells, ( C ) MTT-assay MDA-MB-231 cells.
Bt474 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt474 cells/product/CLS Cell Lines Service GmbH
Average 93 stars, based on 1 article reviews
bt474 cells - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

98
AMS Biotechnology bt474
Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and <t>BT474</t> (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.
Bt474, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt474/product/AMS Biotechnology
Average 98 stars, based on 1 article reviews
bt474 - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

90
Korean Cell Line Bank human breast cancer cell line bt-474
Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and <t>BT474</t> (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.
Human Breast Cancer Cell Line Bt 474, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human breast cancer cell line bt-474/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
human breast cancer cell line bt-474 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd bt474 cells
Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and <t>BT474</t> (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.
Bt474 Cells, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt474 cells/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
bt474 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics mda-mb-231 cell lines icell-h133
Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and <t>BT474</t> (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.
Mda Mb 231 Cell Lines Icell H133, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda-mb-231 cell lines icell-h133/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
mda-mb-231 cell lines icell-h133 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novartis bt474 cell line
Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and <t>BT474</t> (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.
Bt474 Cell Line, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt474 cell line/product/Novartis
Average 90 stars, based on 1 article reviews
bt474 cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Multiplexion GmbH human cell lines bt474 and a431
Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and <t>BT474</t> (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.
Human Cell Lines Bt474 And A431, supplied by Multiplexion GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cell lines bt474 and a431/product/Multiplexion GmbH
Average 90 stars, based on 1 article reviews
human cell lines bt474 and a431 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Snijders Scientific breast cancer cell line bt474
Microarray comparative genomic hybridisation (CGH) profile of the <t>BT474</t> cell line. (A) Bacterial/phage artificial chromosome polymerase chain reaction representations were used as probe DNAs spotted on to the glass slide; (B) oligonucleotides were used as probe DNAs spotted on to the glass slide. Moving average applied to the log2 ratio of the oligo CGH profile. The vertical bars indicate the spacing between the chromosomes.
Breast Cancer Cell Line Bt474, supplied by Snijders Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer cell line bt474/product/Snijders Scientific
Average 90 stars, based on 1 article reviews
breast cancer cell line bt474 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Beuth Verlag GmbH human ductal breast carcinoma cell line bt474
Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.
Human Ductal Breast Carcinoma Cell Line Bt474, supplied by Beuth Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ductal breast carcinoma cell line bt474/product/Beuth Verlag GmbH
Average 90 stars, based on 1 article reviews
human ductal breast carcinoma cell line bt474 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
UPM Biomedicals cell line bt474
Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.
Cell Line Bt474, supplied by UPM Biomedicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell line bt474/product/UPM Biomedicals
Average 90 stars, based on 1 article reviews
cell line bt474 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank bt474 cells
KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of <t>MB231</t> cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.
Bt474 Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt474 cells/product/JCRB Cell Bank
Average 90 stars, based on 1 article reviews
bt474 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
IDEXX bt474 cell line
KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of <t>MB231</t> cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.
Bt474 Cell Line, supplied by IDEXX, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bt474 cell line/product/IDEXX
Average 90 stars, based on 1 article reviews
bt474 cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


MTT-assay. ( A ) MTT-assay T-47D cells, ( B ) MTT-assay BT474 cells, ( C ) MTT-assay MDA-MB-231 cells.

Journal: Breast Cancer : Targets and Therapy

Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro

doi: 10.2147/BCTT.S322619

Figure Lengend Snippet: MTT-assay. ( A ) MTT-assay T-47D cells, ( B ) MTT-assay BT474 cells, ( C ) MTT-assay MDA-MB-231 cells.

Article Snippet: BT474 cells (#300131) and T-47D cells (#300353) were purchased from CLS Cell Lines Service GmbH (Eppelheim, Germany), MDA-MB-231 cells (#92020424) from Sigma-Aldrich (Taufkirchen, Germany).

Techniques: MTT Assay

Ki67 in T-47D, MDA-MB-231 and BT474 cells. Relative intracellular expression of Ki67 RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.

Journal: Breast Cancer : Targets and Therapy

Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro

doi: 10.2147/BCTT.S322619

Figure Lengend Snippet: Ki67 in T-47D, MDA-MB-231 and BT474 cells. Relative intracellular expression of Ki67 RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.

Article Snippet: BT474 cells (#300131) and T-47D cells (#300353) were purchased from CLS Cell Lines Service GmbH (Eppelheim, Germany), MDA-MB-231 cells (#92020424) from Sigma-Aldrich (Taufkirchen, Germany).

Techniques: Expressing

Survivin in T-47D, MDA-MB-231 and BT474 cells. Relative intracellular expression of survivin RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.

Journal: Breast Cancer : Targets and Therapy

Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro

doi: 10.2147/BCTT.S322619

Figure Lengend Snippet: Survivin in T-47D, MDA-MB-231 and BT474 cells. Relative intracellular expression of survivin RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.

Article Snippet: BT474 cells (#300131) and T-47D cells (#300353) were purchased from CLS Cell Lines Service GmbH (Eppelheim, Germany), MDA-MB-231 cells (#92020424) from Sigma-Aldrich (Taufkirchen, Germany).

Techniques: Expressing

Cyclin A2 in T47-D, MDA-MB-231 and BT474 cells. Relative intracellular expression of cyclin A2 RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.

Journal: Breast Cancer : Targets and Therapy

Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro

doi: 10.2147/BCTT.S322619

Figure Lengend Snippet: Cyclin A2 in T47-D, MDA-MB-231 and BT474 cells. Relative intracellular expression of cyclin A2 RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.

Article Snippet: BT474 cells (#300131) and T-47D cells (#300353) were purchased from CLS Cell Lines Service GmbH (Eppelheim, Germany), MDA-MB-231 cells (#92020424) from Sigma-Aldrich (Taufkirchen, Germany).

Techniques: Expressing

Western blots. Western Blot showing control, capsazepine alone, citral, citral + capsazepine, citrathal R, citrathal R + capsazepine, cyclovertal and cyclovertal + capsazepine. ß-tubulin served as loading control in ( A ) T-47D, ( B ) BT474, ( C ) MDA-MB-231.

Journal: Breast Cancer : Targets and Therapy

Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro

doi: 10.2147/BCTT.S322619

Figure Lengend Snippet: Western blots. Western Blot showing control, capsazepine alone, citral, citral + capsazepine, citrathal R, citrathal R + capsazepine, cyclovertal and cyclovertal + capsazepine. ß-tubulin served as loading control in ( A ) T-47D, ( B ) BT474, ( C ) MDA-MB-231.

Article Snippet: BT474 cells (#300131) and T-47D cells (#300353) were purchased from CLS Cell Lines Service GmbH (Eppelheim, Germany), MDA-MB-231 cells (#92020424) from Sigma-Aldrich (Taufkirchen, Germany).

Techniques: Western Blot

Immunocytochemistry. 1: T-47D PCNA. Immunocytochemical staining of T47D cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. 2: T-47D Annexin V. Immunocytochemical staining of T47D cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. Slightly increased staining of the outer cell membrane after citral treatment, more after citrathal R and cyclovertal, compared to the control. 3: BT474 PCNA. Immunocytochemical staining of BT474 cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. 4: BT474 Annexin V. Immunocytochemical staining of BT474 cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Clearly increased staining of the outer cell membrane after citral, cylovertal and mostly after citrathal R treatment compared to the control. 5: MDA-MB-231 PCNA. Immunocytochemical staining of MDA-MB-231 cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced condensation and increased fragmentation of the nucleus and loss of spindle-shape after treatment mostly with citral and citrathal R, but also cyclovertal. Less intensive staining of the nuclei after treatment with citral, citrathal R and cyclovertal compared to the control. 6: MDA-MB-231 Annexin V. Immunohistochemical staining of MDA-MB-231 cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced condensation and increased fragmentation of the nucleus and loss of spindle-shape after treatment with citral, citrathal R and cyclovertal. Increased staining of the outer cell membrane after citral, citrathal R and mostly after cyclovertal treatment compared to the control.

Journal: Breast Cancer : Targets and Therapy

Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro

doi: 10.2147/BCTT.S322619

Figure Lengend Snippet: Immunocytochemistry. 1: T-47D PCNA. Immunocytochemical staining of T47D cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. 2: T-47D Annexin V. Immunocytochemical staining of T47D cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. Slightly increased staining of the outer cell membrane after citral treatment, more after citrathal R and cyclovertal, compared to the control. 3: BT474 PCNA. Immunocytochemical staining of BT474 cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. 4: BT474 Annexin V. Immunocytochemical staining of BT474 cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Clearly increased staining of the outer cell membrane after citral, cylovertal and mostly after citrathal R treatment compared to the control. 5: MDA-MB-231 PCNA. Immunocytochemical staining of MDA-MB-231 cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced condensation and increased fragmentation of the nucleus and loss of spindle-shape after treatment mostly with citral and citrathal R, but also cyclovertal. Less intensive staining of the nuclei after treatment with citral, citrathal R and cyclovertal compared to the control. 6: MDA-MB-231 Annexin V. Immunohistochemical staining of MDA-MB-231 cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced condensation and increased fragmentation of the nucleus and loss of spindle-shape after treatment with citral, citrathal R and cyclovertal. Increased staining of the outer cell membrane after citral, citrathal R and mostly after cyclovertal treatment compared to the control.

Article Snippet: BT474 cells (#300131) and T-47D cells (#300353) were purchased from CLS Cell Lines Service GmbH (Eppelheim, Germany), MDA-MB-231 cells (#92020424) from Sigma-Aldrich (Taufkirchen, Germany).

Techniques: Immunocytochemistry, Staining, Immunohistochemical staining

Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and BT474 (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.

Journal: Nucleic acids research

Article Title: Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity.

doi: 10.1093/nar/gkz1151

Figure Lengend Snippet: Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and BT474 (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.

Article Snippet: FFPE cell blocks and tissues FFPE cell blocks of the cell lines MCF7, BT474 and SKBR3 (AMS Biotechnology, Abingdon, UK) with HER2 expression levels of 1+, 2+ and 3+, respectively, were used as references.

Techniques: RNA In Situ Hybridization, Amplification, Binding Assay, Fluorescence, Gene Expression

Figure 2. Detection of HER2 expression status by RNA in situ hybridization using internal positive and negative controls. (A) Fluorescence images of the signals detected for HER2, dapB, and ActB in a mammary carcinoma section. Scale bar: 100 m. (B) Quantitative analysis of the fluorescence intensity of FISH signals detected for HER2, dapB, and ActB integrated per sectioned cell for FFPE sections of the breast cancer cell lines MCF7, SKBR3, and BT474 (see Figure 1) as well as the mammary carcinoma from (A). 100 ms excitation.

Journal: Nucleic acids research

Article Title: Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity.

doi: 10.1093/nar/gkz1151

Figure Lengend Snippet: Figure 2. Detection of HER2 expression status by RNA in situ hybridization using internal positive and negative controls. (A) Fluorescence images of the signals detected for HER2, dapB, and ActB in a mammary carcinoma section. Scale bar: 100 m. (B) Quantitative analysis of the fluorescence intensity of FISH signals detected for HER2, dapB, and ActB integrated per sectioned cell for FFPE sections of the breast cancer cell lines MCF7, SKBR3, and BT474 (see Figure 1) as well as the mammary carcinoma from (A). 100 ms excitation.

Article Snippet: FFPE cell blocks and tissues FFPE cell blocks of the cell lines MCF7, BT474 and SKBR3 (AMS Biotechnology, Abingdon, UK) with HER2 expression levels of 1+, 2+ and 3+, respectively, were used as references.

Techniques: Expressing, RNA In Situ Hybridization, Fluorescence

Figure 3. Single color multiplexed RNA-ISH for the detection of breast cancer biomarkers. (A) The primary probes for ER, PgR, and HER2 were delivered to spatially distinct regions of a mammary carcinoma section using a microfluidic chip (schematic in upper left corner). Fluorescence images of the signal detected for the breast cancer biomarkers ER, PgR and HER2 in a mammary carcinoma section. Scale bar: 100 m. (B) Fluorescence intensity of FISH signals detected for ER, PgR and HER2 integrated per sectioned cell for FFPE sections of the breast cancer cell lines MCF7, SKBR3 and BT474 (see Supplementary Figure S7) as well as the mammary carcinoma from (A). 500 ms excitation.

Journal: Nucleic acids research

Article Title: Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity.

doi: 10.1093/nar/gkz1151

Figure Lengend Snippet: Figure 3. Single color multiplexed RNA-ISH for the detection of breast cancer biomarkers. (A) The primary probes for ER, PgR, and HER2 were delivered to spatially distinct regions of a mammary carcinoma section using a microfluidic chip (schematic in upper left corner). Fluorescence images of the signal detected for the breast cancer biomarkers ER, PgR and HER2 in a mammary carcinoma section. Scale bar: 100 m. (B) Fluorescence intensity of FISH signals detected for ER, PgR and HER2 integrated per sectioned cell for FFPE sections of the breast cancer cell lines MCF7, SKBR3 and BT474 (see Supplementary Figure S7) as well as the mammary carcinoma from (A). 500 ms excitation.

Article Snippet: FFPE cell blocks and tissues FFPE cell blocks of the cell lines MCF7, BT474 and SKBR3 (AMS Biotechnology, Abingdon, UK) with HER2 expression levels of 1+, 2+ and 3+, respectively, were used as references.

Techniques: Fluorescence

Microarray comparative genomic hybridisation (CGH) profile of the BT474 cell line. (A) Bacterial/phage artificial chromosome polymerase chain reaction representations were used as probe DNAs spotted on to the glass slide; (B) oligonucleotides were used as probe DNAs spotted on to the glass slide. Moving average applied to the log2 ratio of the oligo CGH profile. The vertical bars indicate the spacing between the chromosomes.

Journal:

Article Title: High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides

doi: 10.1136/jcp.2003.013029

Figure Lengend Snippet: Microarray comparative genomic hybridisation (CGH) profile of the BT474 cell line. (A) Bacterial/phage artificial chromosome polymerase chain reaction representations were used as probe DNAs spotted on to the glass slide; (B) oligonucleotides were used as probe DNAs spotted on to the glass slide. Moving average applied to the log2 ratio of the oligo CGH profile. The vertical bars indicate the spacing between the chromosomes.

Article Snippet: Genomic DNA was isolated from normal kidney (female donor), blood (male donor), or liver (female donor) as a reference, and from the breast cancer cell line BT474, according to Snijders et al . 7 The DNA from the GM00143 cell line (Coriell Institute for Medical Research, Camden, New Jersey, USA) was provided by the Albertson laboratory (University of California, San Francisco, USA).

Techniques: Microarray, Hybridization, Polymerase Chain Reaction

Microarray comparative genomic hybridisation (CGH) profile of the long arm of chromosome 17 of the BT474 cell line. Grey triangles, bacterial/phage artificial chromosome polymerase chain reaction representations were used as probe DNAs spotted on to the glass slide; black squares, oligonucleotides were used as probe DNAs spotted on to the glass slide (log2 ratio without moving average). The horizontal bars indicate the two separate amplicons observed.

Journal:

Article Title: High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides

doi: 10.1136/jcp.2003.013029

Figure Lengend Snippet: Microarray comparative genomic hybridisation (CGH) profile of the long arm of chromosome 17 of the BT474 cell line. Grey triangles, bacterial/phage artificial chromosome polymerase chain reaction representations were used as probe DNAs spotted on to the glass slide; black squares, oligonucleotides were used as probe DNAs spotted on to the glass slide (log2 ratio without moving average). The horizontal bars indicate the two separate amplicons observed.

Article Snippet: Genomic DNA was isolated from normal kidney (female donor), blood (male donor), or liver (female donor) as a reference, and from the breast cancer cell line BT474, according to Snijders et al . 7 The DNA from the GM00143 cell line (Coriell Institute for Medical Research, Camden, New Jersey, USA) was provided by the Albertson laboratory (University of California, San Francisco, USA).

Techniques: Microarray, Hybridization, Polymerase Chain Reaction

Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.

Journal: BioMed Research International

Article Title: Preclinical and Clinical Effects of Mistletoe against Breast Cancer

doi: 10.1155/2014/785479

Figure Lengend Snippet: Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.

Article Snippet: In 2006, Beuth et al. [ ] studied the human ductal breast carcinoma cell line BT474 and proved the direct antitumor efficacy of Helixor M and Helixor A using a calorimetric in vitro assay.

Techniques: In Vitro, In Vivo, Activity Assay, Purification, Inhibition, Transplantation Assay

KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of MB231 cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.

Journal: American Journal of Cancer Research

Article Title: KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival

doi:

Figure Lengend Snippet: KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of MB231 cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.

Article Snippet: Cell culture MCF10A, MCF7, SKBR3, BT474, and MB231 cells were obtained from the JCRB (Japanese Collection of Research Bioresources) Cell Bank.

Techniques: Expressing, Transfection